Proxim Diagnostics
Sunnyvale
About Proxim Diagnostics
Proxim Diagnostics develops a next generation handheld immuno diagnostic device. It performs the most important laboratory tests near the patient using whole blood without any sacrifice in sensitivity and precision. Proxim Diagnostics' device can also test blood gases, electrolytes and metabolites, infectious disease antigens and antibodies. Special attention was given to the disposable test cartridge, which can be manufactured at a low cost. Proxim’s unique combination of high performance and low cost not only make it ideal for hospital Emergency Departments in the USA but also in other settings around the world.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $22.9M
- Last round: Series Unknown (Nov 2022)
- Website: proximdx.com
- Phone: 4083296044
Industries & Categories
Biotechnology, Health Diagnostics, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/proxim-diagnostics-14395 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.